Scherle Peggy Insider Trades

Insider Trading History

Track insider trading activity for Scherle Peggy. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Prelude Therapeutics
Prelude Therapeutics PRLD
Chief Scientific Officer
Holding Value $1.03M 230,000 shares
Last Trade
Feb 04, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$529k 230,000 shares
$2.30
$4.46
Prelude Therapeutics
Prelude Therapeutics PRLD
Chief Scientific Officer
Holding Value $781k 175,000 shares
Last Trade
Feb 04, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$194k 175,000 shares
$1.11
$4.46
Prelude Therapeutics
Prelude Therapeutics PRLD
Chief Scientific Officer
Holding Value $669k 150,000 shares
Last Trade
Mar 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$689k 150,000 shares
$4.59
$4.46
Prelude Therapeutics
Prelude Therapeutics PRLD
Chief Scientific Officer
Holding Value $602k 135,000 shares
Last Trade
Feb 07, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$972k 135,000 shares
$7.20
$4.46
Prelude Therapeutics
Prelude Therapeutics PRLD
Chief Scientific Officer
Holding Value $446k 100,000 shares
Last Trade
Feb 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.06M 100,000 shares
$10.58
$4.46
Prelude Therapeutics
Prelude Therapeutics PRLD
Chief Scientific Officer
Holding Value $786k 176,234 shares
Last Trade
Aug 27, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$216k 6,014 shares
$35.91
$4.46
Prelude Therapeutics
Prelude Therapeutics PRLD
Chief Scientific Officer
Holding Value $121k 27,018 shares
Last Trade
Aug 27, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$226k 6,014 shares
$37.57
$4.46
Prelude Therapeutics
Prelude Therapeutics PRLD
Chief Scientific Officer
Holding Value $798k 178,934 shares
Last Trade
Aug 27, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$226k 6,014 shares
$37.57
$4.46
Prelude Therapeutics
Prelude Therapeutics PRLD
Chief Scientific Officer
Holding Value $771k 172,920 shares
Last Trade
Aug 26, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$59.8k 1,700 shares
$35.19
$4.46
Prelude Therapeutics
Prelude Therapeutics PRLD
Chief Scientific Officer
Holding Value $779k 174,620 shares
Last Trade
Aug 26, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$58.1k 1,700 shares
$34.16
$4.46
Prelude Therapeutics
Prelude Therapeutics PRLD
Chief Scientific Officer
Holding Value $147k 33,032 shares
Last Trade
Aug 26, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$58.1k 1,700 shares
$34.16
$4.46
Prelude Therapeutics
Prelude Therapeutics PRLD
Chief Scientific Officer
Holding Value $190k 42,672 shares
Last Trade
Aug 13, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$73.5k 2,286 shares
$32.17
$4.46
Prelude Therapeutics
Prelude Therapeutics PRLD
Chief Scientific Officer
Holding Value $781k 175,206 shares
Last Trade
Aug 13, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$73.5k 2,286 shares
$32.17
$4.46
Prelude Therapeutics
Prelude Therapeutics PRLD
Chief Scientific Officer
Holding Value $771k 172,920 shares
Last Trade
Aug 13, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$80.2k 2,286 shares
$35.07
$4.46
Prelude Therapeutics
Prelude Therapeutics PRLD
Chief Scientific Officer
Holding Value $860k 192,920 shares
Last Trade
Jul 27, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$693k 20,000 shares
$34.65
$4.46
Prelude Therapeutics
Prelude Therapeutics PRLD
Chief Scientific Officer
Holding Value $163k 36,460 shares
Last Trade
Jul 27, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$693k 20,000 shares
$34.65
$4.46
Prelude Therapeutics
Prelude Therapeutics PRLD
Chief Scientific Officer
Holding Value $774k 173,600 shares
Last Trade
Jul 27, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$709k 20,000 shares
$35.47
$4.46
Prelude Therapeutics
Prelude Therapeutics PRLD
Chief Scientific Officer
Holding Value $424k 95,000 shares
Last Trade
Jul 20, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.97M 95,000 shares
$31.23
$4.46
Prelude Therapeutics
Prelude Therapeutics PRLD
Chief Scientific Officer
Holding Value $252k 56,460 shares
Last Trade
May 07, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$416k 10,000 shares
$41.61
$4.46
Prelude Therapeutics
Prelude Therapeutics PRLD
Chief Scientific Officer
Holding Value $798k 178,956 shares
Last Trade
May 07, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$408k 10,000 shares
$40.82
$4.46

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up